Psychiatry Research
Volume 136, Issue 2 , Pages 211-221, 15 September 2005

Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder

  • Rajiv Tandon

      Affiliations

    • Department of Psychiatry (Adjunct), University of Florida, Gainesville, FL, USA
    • ,
  • Robert F. DeVellis

      Affiliations

    • Department of Health Behavior and Health Education, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • ,
  • Jian Han

      Affiliations

    • Biostatistics and Programming, Bristol-Myers Squibb Company, Wallingford, CT, USA
    • ,
  • Hong Li

      Affiliations

    • Global Epidemiology and Outcomes Research, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 203 677 5787; fax: +1 203 677 5797.
    • ,
  • Sophia Frangou

      Affiliations

    • Section of Neurobiology of Psychosis, Institute of Psychiatry, London, UK
    • ,
  • Serdar Dursun

      Affiliations

    • Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK
    • ,
  • IAQ Validation Study Group
    • ,
  • Jean-Noel Beuzen

      Affiliations

    • International Medical Affairs, Bristol-Myers Squibb Company, Braine-I'Alleud, Belgium
    • ,
  • William Carson

      Affiliations

    • Global Development and Commercialization, Otsuka America Pharmaceutical Inc., Princeton, NJ, USA
    • ,
  • Patricia K. Corey-Lisle

      Affiliations

    • Global Epidemiology and Outcomes Research, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660, USA
    • ,
  • Bruno Falissard

      Affiliations

    • Department of Public Health, Hôpital Paul Brousse, Villejuif, France
    • ,
  • Darlene N. Jody

      Affiliations

    • Global Medical Marketing, Bristol-Myers Squibb Company, Princeton, NJ, USA
    • ,
  • Mary J. Kujawa

      Affiliations

    • US Medical Affairs, Bristol-Myers Squibb Company, Princeton, NJ, USA
    • ,
  • Gilbert L'Italien

      Affiliations

    • Global Epidemiology and Outcomes Research, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660, USA
    • ,
  • Ronald N. Marcus

      Affiliations

    • Global Clinical Research, Bristol-Myers Squibb Company, Wallingford, CT, USA
    • ,
  • Robert D. McQuade

      Affiliations

    • Global Medical Marketing, Bristol-Myers Squibb Company, Princeton, NJ, USA
    • ,
  • Saurabh Ray

      Affiliations

    • Global Epidemiology and Outcomes Research, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660, USA
    • ,
  • Pascal Van Peborgh

      Affiliations

    • Medical Affairs, Bristol-Myers Squibb Company, Lounslow, UK

Received 30 August 2004; received in revised form 17 March 2005; accepted 26 May 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0165-1781(05)00152-6

doi:10.1016/j.psychres.2005.05.006

Psychiatry Research
Volume 136, Issue 2 , Pages 211-221, 15 September 2005

Article Tools

* Image Usage & Resolution